About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Reactions Weekly
›
top-articles
Reactions Weekly
0.0
(top 100%)
impact factor
112.8K
(top 0.1%)
papers
749
(top 50%)
citations
6
(top 50%)
h
-index
0.0
(top 100%)
impact factor
246.9K
all documents
1.2K
doc citations
10
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Pfizer-BioNTech COVID-19 vaccine safe in children
Reactions Weekly
2022
30
2
Factor-VIII/von Willebrand factor
Reactions Weekly
2015
27
3
Nicardipine/tacrolimus interaction
Reactions Weekly
2015
20
4
Wasp-venom-allergy-immunotherapy/yellow-jacket-venom
Reactions Weekly
2015
16
5
The European Agency for the Evaluation of Medicinal Products (EMEA) patients' working group,
Reactions Weekly
2003
15
6
Antiretrovirals/warfarin interaction
Reactions Weekly
2018
11
7
The EMA has released two more modules of its guideline on good pharmacovigilance practices (GVP).
Reactions Weekly
2012
8
8
New warning of nusinersen-related communicating hydrocephalus
Reactions Weekly
2018
8
9
Warfarin/zingiber-officiales interaction
Reactions Weekly
2019
8
10
Dopamine receptor agonists
Reactions Weekly
2020
8
11
Pfizer-BioNTech COVID-19 vaccine safe with clozapine
Reactions Weekly
2022
8
12
DPP-4 inhibitors may cause severe joint pain
Reactions Weekly
2015
7
13
Safety of second Pfizer-BioNTech COVID-19 vaccine booster
Reactions Weekly
2022
7
14
Omeprazole/warfarin interaction
Reactions Weekly
2019
6
15
TTS rare after AstraZeneca COVID-19 vaccine
Reactions Weekly
2022
6
16
Paradoxical findings in halted MOXCON trial
Reactions Weekly
1999
5
17
Human papillomavirus vaccine
Reactions Weekly
2019
5
18
MHRA Yellow Card reports on COVID-19 vaccine adverse reactions
Reactions Weekly
2021
5
19
March 2021 PRAC meeting highlights include COVID-19 vaccine update
Reactions Weekly
2021
5
20
Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Reactions Weekly
2022
5
21
The 'Erice Declaration' ??? communicating drug safety information
Reactions Weekly
1997
4
22
Vinca alkaloids
Reactions Weekly
2007
4
23
Second HPRA safety update on COVID-19 vaccines
Reactions Weekly
2021
4
24
Histamine H1 receptor antagonists
Reactions Weekly
2013
3
25
Traditional Chinese medicine
Reactions Weekly
2013
3
26
UMC investigates use of observational data to id ADRs
Reactions Weekly
2013
3
27
EMA good practice guide on medication errors
Reactions Weekly
2015
3
28
Immune checkpoint inhibitors: fatal toxic effects
Reactions Weekly
2018
3
29
VigiBase now contains around 17 million ADR reports
Reactions Weekly
2018
3
30
FDA requests market withdrawal of all ranitidine products
Reactions Weekly
2020
3
31
FDA requires labelling changes for drugs treating opioid overdose
Reactions Weekly
2020
3
32
Global operation targets rise in counterfeit COVID-related medical items
Reactions Weekly
2020
3
33
Allopurinol/azathioprine interaction
Reactions Weekly
2021
3
34
FDA reports recall of Innova COVID-19 antigen rapid qualitative test
Reactions Weekly
2021
3
35
Pfizer recalls all lots of varenicline in USA due to nitrosamine
Reactions Weekly
2021
3
36
Myocarditis rare after COVID-19 mRNA vaccination
Reactions Weekly
2021
3
37
Safety aspects of intravenous ciprofloxacin in clinical practice
Reactions Weekly
1995
2
38
US FDA to waive non-serious adverse event reporting
Reactions Weekly
1997
2
39
EMEA recommends restricting nimesulide use
Reactions Weekly
2007
2
40
The Canadian Adverse Drug Reaction Monitoring Program has been renamed as Canada Vigilance.
Reactions Weekly
2008
2
41
Fentanyl overdose
Reactions Weekly
2010
2
42
US FDA 2009 drug safety warnings analysed
Reactions Weekly
2012
2
43
Filgrastim/methotrexate
Reactions Weekly
2013
2
44
WEB-RADR: new social media project for ADR monitoring in EU
Reactions Weekly
2014
2
45
Vantictumab and OMP-54F78 trials on hold to assess adverse events
Reactions Weekly
2014
2
46
PRAC recommends restricting use of bromocriptine
Reactions Weekly
2014
2
47
Escitalopram withdrawal
Reactions Weekly
2014
2
48
New EMA recommendations on Tecfidera
Reactions Weekly
2015
2
49
Calcium polystyrene sulfonate
Reactions Weekly
2015
2
50
INTERPOL targets illicit sale of fake medicines, products online
Reactions Weekly
2016
2
site/software ©
exaly
; All materials licenced under
CC by-SA
.